Helicos Sells Sequencer to Undisclosed Biotech Firm

To date, Helicos has announced instrument placements or orders at Stanford University, the Broad Institute, the Dana-Farber Cancer Institute, and the University of Maryland. The new order would be the first that it has disclosed for a commercial entity.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.